Natco Pharma receives EIR for Chemical Division in Chennai
From USFDA
Natco Pharma has received successful Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the inspection conducted, during the period 08 February - 12 February 2016, at its Chemical Division, Chennai, India (named NATCO Organics, prior to amalgamation into the company).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content